Point mutation of tyrosine 759 of the IL-6 family cytokine receptor, gp130, augments collagen-induced arthritis in DBA/1J mice
- PMID: 19228423
- PMCID: PMC2652421
- DOI: 10.1186/1471-2474-10-23
Point mutation of tyrosine 759 of the IL-6 family cytokine receptor, gp130, augments collagen-induced arthritis in DBA/1J mice
Abstract
Background: Knock-in mice (gp130F759) with a Y759F point mutation in gp130, a signal transducing receptor subunit shared by members of the IL-6 cytokine family, show sustained activation of STAT3, enhanced acute-phase or immune responses, and autoimmune arthritis. We conducted a detailed analysis of collagen-induced arthritis (CIA) in gp130F759 with a DBA/1J background (D/J.gp130F759).
Methods: We backcrossed gp130F759 to C57BL/6 and DBA/1J, and compared the pathologic changes, including occurrence of arthritis, in the two distinct genetic backgrounds. We analyzed CIA in D/J.gp130F759 and investigated the effects of methotrexate (MTX) on CIA.
Results: C57BL/6 background gp130F759 mice, but not D/J.gp130F759, spontaneously developed polyarthritis and glomerulonephritis. On the other hand, keratitis of the eyes only developed in D/J.gp130F759, indicating the influence of genetic background on disease development in gp130F759 mice. Resistance of the DBA/1J background against spontaneous arthritis urged us to examine CIA in D/J.gp130F759. CIA in D/J.gp130F759 was more severe, with greater bone destruction, than the control mice. After collagen immunization, splenomegaly and serum levels of rheumatoid factor and anti-DNA antibody were augmented in D/J.gp130F759. Bio-Plex analysis of serum cytokines revealed increased IL-12p40 and PDGF-BB before immunization, and increased levels of IFN-gamma, IL-17, TNF-alpha, IL-9, and MIP-1beta 8 days after the booster dose. IL-6 and PDGF-BB in D/J.gp130F759 showed distinct kinetics from the other cytokines; higher levels were observed after arthritis development. MTX partially attenuated the development of arthritis and inhibited bone destruction in D/J.gp130F759, with reduction of anti-type II collagen antibody levels, suggesting that MTX mainly affects antigen-specific immune responses in CIA.
Conclusion: The Tyr-759 point mutation of the IL-6 family cytokine receptor subunit, gp130, caused autoimmune disease, and this was also influenced by the genetic background. CIA in D/J.gp130F759 is useful for evaluating drugs in a relatively short period because sustained activation of STAT3 may enhance the disease symptoms.
Figures









Similar articles
-
IL-6-PAD4 axis in the earliest phase of arthritis in knock-in gp130F759 mice, a model for rheumatoid arthritis.RMD Open. 2019 Jun 21;5(2):e000853. doi: 10.1136/rmdopen-2018-000853. eCollection 2019. RMD Open. 2019. PMID: 31321075 Free PMC article.
-
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.Arthritis Res. 1999;1(1):81-91. doi: 10.1186/ar14. Epub 1999 Oct 26. Arthritis Res. 1999. PMID: 11056663 Free PMC article.
-
Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.J Ethnopharmacol. 2013 Jan 9;145(1):109-17. doi: 10.1016/j.jep.2012.10.038. Epub 2012 Nov 1. J Ethnopharmacol. 2013. PMID: 23123796
-
The point mutation of tyrosine 759 of the IL-6 family cytokine receptor gp130 synergizes with HTLV-1 pX in promoting rheumatoid arthritis-like arthritis.Int Immunol. 2004 Mar;16(3):455-65. doi: 10.1093/intimm/dxh045. Int Immunol. 2004. PMID: 14978019
-
IL-17-deficient allogeneic bone marrow transplantation prevents the induction of collagen-induced arthritis in DBA/1J mice.Exp Mol Med. 2012 Nov 30;44(11):694-705. doi: 10.3858/emm.2012.44.11.078. Exp Mol Med. 2012. PMID: 23114425 Free PMC article.
Cited by
-
Ameliorated Autoimmune Arthritis and Impaired B Cell Receptor-Mediated Ca2+ Influx in Nkx2-3 Knock-out Mice.Int J Mol Sci. 2020 Aug 26;21(17):6162. doi: 10.3390/ijms21176162. Int J Mol Sci. 2020. PMID: 32859051 Free PMC article.
-
Recent advances in neutralizing the IL-6 pathway in arthritis.Open Access Rheumatol. 2009 Oct 5;1:133-150. doi: 10.2147/oarrr.s6266. eCollection 2009. Open Access Rheumatol. 2009. PMID: 27789987 Free PMC article. Review.
-
Potential roles of IL-9 in the pathogenesis of systemic lupus erythematosus.Am J Clin Exp Immunol. 2012 Apr 23;1(1):28-32. Print 2012. Am J Clin Exp Immunol. 2012. PMID: 23885312 Free PMC article.
-
Daily oral administration of low-dose methotrexate has greater antirheumatic effects in collagen-induced arthritis rats.J Pharm Pharmacol. 2017 Sep;69(9):1145-1154. doi: 10.1111/jphp.12752. Epub 2017 May 31. J Pharm Pharmacol. 2017. PMID: 28560778 Free PMC article.
-
New Studies of Pathogenesis of Rheumatoid Arthritis with Collagen-Induced and Collagen Antibody-Induced Arthritis Models: New Insight Involving Bacteria Flora.Autoimmune Dis. 2021 Mar 25;2021:7385106. doi: 10.1155/2021/7385106. eCollection 2021. Autoimmune Dis. 2021. PMID: 33833871 Free PMC article. Review.
References
-
- Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356–361. - PubMed
-
- Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397–440. - PubMed
-
- McInnes IB, Liew FY. Cytokine networks-towards new therapies for rheumatoid arthritis. Nat Clin Pract Rheumatol. 2005;1:31–39. - PubMed
-
- Hirano T. Interleukin 6 and its receptor: ten years later. Int Rev Immunol. 1998;16:249–284. - PubMed
-
- Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatsuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA. 1987;84:228–231. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous